Atrial Fibrillation
Atrial Fibrillation (AF) is the most common type of arrhythmia, characterized by rapid and irregular beating of the atrial chambers of the heart, leading to symptoms like chest pain, dizziness, and fatigue, and increasing the risk of stroke. It often begins as short episodes of abnormal heartbeats, which can evolve into sustained irregular rhythms over time.
Health Outcomes
- Changed Heart Rate
- Improved Anticoagulatory Effects
- Improved Antithrombotic Prevention
- Improved Cardioprotective Activity
- Improved Cardiovascular Disease Outcomes
- Improved Cardiovascular Function
- Improved Cardiovascular Health
- Improved Clinical Outcome
- Improved Heart Rate Variability
- Improved Prognosis After Bacteremia Recovery
- Improved Vagal Reactivation
- Induced Health-Related Benefits
- No Change in Major Cardiovascular Event
- No Difference in Adverse Events
- Preserved Cardiac Function
- Reduced Cardiac Arrest Risk
- Reduced Cardiac Output
- Reduced Cardiovascular Dysfunction
- Reduced Cardiovascular Mortality
- Reduced Cerebrovascular Mortality
- Reduced Emergency Care Unit Stay Duration
- Reduced Episode Frequency
- Reduced Heart Rate Variability
- Reduced Hospital Readmission Risk
- Reduced INR
- Reduced Incidence of Adverse Events
- Reduced Ischemic Stroke Mortality
- Reduced Mortality Rate Before Discharge
- Reduced Mortality Risk
- Reduced Omission Errors
- Reduced Recurrence Risk
- Reduced Serious Adverse Events
- Reduced Stroke Mortality Risk
- Reduced Sympathetic Hyperactivity
- Reduced Thrombosis